Cara Therapeutics announces pricing of $85.5 million offering of common stock
Cara Therapeutics announced pricing of its underwritten public offering of 4,500,000 shares of its common stock at a public offering price of $19.00 per share. Cara Therapeutics granted underwriters a 30-day option to purchase up to 675,000 additional shares of its common stock on the same terms. July 18, 2018